# Metal complexes in medicine: structural scaffolds vs. functional centres

## TL;DR

This review explores how metal complexes in medicine can act as either stable structures for biomolecule recognition or dynamic centers for biological activity.

## Contribution

The paper introduces a conceptual framework to categorize metal-based therapeutics based on their structural or functional roles.

## Key findings

- Scaffold-dominated complexes use rigid structures for selective biomolecule recognition.
- Functional-centre-dominated complexes rely on metal-driven reactivity for biological interactions.
- Strategies combining structural stability with target-specific activation are emphasized for improved drug design.

## Abstract

Metal complexes occupy a distinctive position in medicinal chemistry by combining well-defined three-dimensional structures with tuneable reactivity that cannot be readily achieved using purely organic compounds. This review examines metal-based therapeutics through a unifying conceptual framework that distinguishes between coordination complexes functioning primarily as inert structural scaffolds and those in which the metal centre serves as the dominant functional element. Scaffold-dominated complexes exploit kinetically stable coordination geometries to present ligands in rigid, stereochemically defined arrangements, enabling selective recognition of proteins and nucleic acids through shape complementarity and spatial control. In contrast, functional-centre-dominated complexes derive biological activity from metal-centred processes such as ligand exchange, redox cycling, catalysis, and photophysical activation, allowing dynamic and stimulus-responsive interactions with biological systems. The review highlights representative examples across both paradigms and emphasizes strategies that intentionally bridge structural stability with controlled activation at the target site. Emerging stimulus-responsive and multimodal approaches illustrate how metal complexes can be integrated into optimized therapeutic systems that align chemical reactivity with biological context and treatment modality. Collectively, this perspective underscores the unique structural and mechanistic space occupied by metal complexes in medicine and outlines design principles to guide the development of next-generation metallodrugs with improved selectivity, efficacy, and translational potential.

This review categorises metal-based therapeutics by their primary role, distinguishing between complexes acting as inert structural scaffolds for biomolecule recognition and those where the metal centre drives dynamic functional reactivity.